Invesaro

Stocks Comparison

Bioceres Crop Solutions vs ICL: revenue, profit, margins and growth compared

Bioceres Crop Solutions brought in $335.1M of revenue in fiscal 2025, ICL $7.2B in fiscal 2025. Revenue changed by -27.9% at Bioceres Crop Solutions and +4.6% at ICL on the year before, so ICL grew faster. Bioceres Crop Solutions kept -16.5% of its revenue as net profit, ICL 3.2%.

Side by side, latest fiscal year

BIOXICL
Fiscal year endedFY2025 (June 30, 2025)FY2025 (December 31, 2025)
Revenue$335.1M$7.2B
Revenue growth-27.9%+4.6%
Net income-$55.4M$226M
Net margin-16.5%3.2%
Free cash flow$44.3Mn/a
Free cash flow margin13.2%n/a
Earnings per share (diluted)-$0.88$0.18
Cash$32.7M$291M
Debtn/an/a
Price to earningsn/an/a
Market value$23.7M$6.6B
Dividend yieldn/an/a
Rank by revenue in sector#347 of 518 · Industrials#95 of 518 · Industrials

Over the years

Revenue
BIOX FY2019: $133.5MBIOX FY2019: $160.6MBIOX FY2020: $173.1MBIOX FY2021: $209.5MBIOX FY2022: $334.8MBIOX FY2023: $420.1MBIOX FY2024: $464.8MBIOX FY2025: $335.1MICL FY2018: $5.6BICL FY2019: $5.3BICL FY2020: $5BICL FY2021: $7BICL FY2022: $10BICL FY2023: $7.5BICL FY2024: $6.8BICL FY2025: $7.2BFY18FY19FY20FY21FY22FY23FY24FY25
BIOX $335.1MICL $7.2B
Net income
BIOX FY2019: -$11MBIOX FY2019: -$18.4MBIOX FY2020: $3.4MBIOX FY2021: -$6.9MBIOX FY2022: -$7.2MBIOX FY2023: $18.8MBIOX FY2024: $4.3MBIOX FY2025: -$55.4MICL FY2018: $1.2BICL FY2019: $475MICL FY2020: $11MICL FY2021: $783MICL FY2022: $2.2BICL FY2023: $647MICL FY2024: $407MICL FY2025: $226MFY18FY19FY20FY21FY22FY23FY24FY25
BIOX -$55.4MICL $226M
Net margin
BIOX FY2019: -8.3%BIOX FY2019: -11.4%BIOX FY2020: 1.9%BIOX FY2021: -3.3%BIOX FY2022: -2.2%BIOX FY2023: 4.5%BIOX FY2024: 0.9%BIOX FY2025: -16.5%ICL FY2018: 22.3%ICL FY2019: 9.0%ICL FY2020: 0.2%ICL FY2021: 11.3%ICL FY2022: 21.6%ICL FY2023: 8.6%ICL FY2024: 5.9%ICL FY2025: 3.2%FY18FY19FY20FY21FY22FY23FY24FY25
BIOX -16.5%ICL 3.2%
Revenue growth
BIOX FY2019: +20.3%BIOX FY2020: +7.8%BIOX FY2021: +21.0%BIOX FY2022: +59.8%BIOX FY2023: +25.4%BIOX FY2024: +10.7%BIOX FY2025: -27.9%ICL FY2019: -5.1%ICL FY2020: -4.3%ICL FY2021: +37.9%ICL FY2022: +44.0%ICL FY2023: -24.8%ICL FY2024: -9.2%ICL FY2025: +4.6%FY19FY20FY21FY22FY23FY24FY25
BIOX -27.9%ICL +4.6%
Free cash flow
BIOX FY2019: $15.6MBIOX FY2019: $27.7MBIOX FY2020: $7.7MBIOX FY2021: -$9MBIOX FY2022: -$21MBIOX FY2023: -$8.8MBIOX FY2024: $31.9MBIOX FY2025: $44.3MFY19FY20FY21FY22FY23FY24FY25
BIOX $44.3MICL

Fiscal years as each company reports them; the two may end in different months.

Questions about Bioceres Crop Solutions and ICL

Which is bigger by revenue, Bioceres Crop Solutions or ICL?

ICL is bigger by revenue: $7.2B in fiscal 2025, against $335.1M for Bioceres Crop Solutions in fiscal 2025.

Which keeps more of its revenue as profit, Bioceres Crop Solutions or ICL?

Bioceres Crop Solutions had a net margin of -16.5% in fiscal 2025; ICL had 3.2% in fiscal 2025.

Which grew revenue faster, Bioceres Crop Solutions or ICL?

In their latest fiscal years revenue changed by -27.9% at Bioceres Crop Solutions and +4.6% at ICL.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies